greeksoup/ stock research

Johnson & Johnson (JNJ) Q1 FY2026 earnings: revenue $24.1 billion, up 9.9% on the year

Johnson & Johnson (JNJ) reported revenue of $24.1 billion for Q1 FY2026, the quarter ended 29 March 2026, up 9.9% on the same quarter a year earlier. Net income was $5.2 billion, down 52.4% on the year, and diluted earnings per share $2.14. The figures are the company's own, from the 10-Q it filed with the SEC on 22 April 2026.

Revenue
$24.1 billion
+9.9% on the year · -2.0% on the quarter
Q2 FY2024Q1 FY2026
Operating margin
n/a
Q2 FY2024Q1 FY2026
Net income
$5.2 billion
-52.4% on the year · +2.3% on the quarter
Q2 FY2024Q1 FY2026
Diluted EPS
$2.14
-52.9% on the year · +1.9% on the quarter
Q2 FY2024Q1 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 5 raised, 1 kept.

  • Reported sales rose 9.9%: Reported sales were $24.1 Billion, up 9.9%. Operational growth was 6.4% and adjusted operational growth was 5.3%; both are non-GAAP measures.
  • Net earnings and EPS fell: Net earnings were $5,235 million against $10,999 million, down 52.4%. Diluted EPS was $2.14 against $4.54, down 52.9%. The document gives no cause for the decline.
  • ICOTYDE approved for plaque psoriasis: The FDA approved ICOTYDE (icotrokinra), described as a targeted oral peptide, for plaque psoriasis in the U.S.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ1 FY2026Q4 FY2025Q1 FY2025On the quarterOn the yearLast 8 quarters
Revenue24,06224,56421,893-2.0%+9.9%
Cost of revenue8,1067,9687,357+1.7%+10.2%
Gross profit15,95616,59614,536-3.9%+9.8%
Gross margin66.3%67.6%66.4%
Research and development3,5274,2523,225-17.1%+9.4%
Selling, general and administrative6,0346,7535,112-10.6%+18.0%
Interest expense272214204+27.1%+33.3%
Pre-tax income5,9904,96613,631+20.6%-56.1%
Income tax755-1502,632-71.3%
Effective tax rate12.6%-3.0%19.3%
Net income5,2355,11610,999+2.3%-52.4%
Net margin21.8%20.8%50.2%
Diluted EPS$2.14$2.10$4.54+1.9%-52.9%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2026Q4 FY2025Q1 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow2,5147,3094,174-65.6%-39.8%
Capital expenditure1,0491,837795-42.9%+31.9%
Free cash flow1,4655,4723,379-73.2%-56.6%
Free cash flow margin6.1%22.3%15.4%
Cash from investing-1,040-4,485-297
Cash from financing530-1,36910,422-94.9%
Depreciation and amortisation2,0042,0111,772-0.3%+13.1%
Share-based compensation300309288-2.9%+4.2%
Buybacks4,0281,9242,127+109.4%+89.4%
Dividends paid3,1313,1312,9890.0%+4.8%
Dividend per share$1.30n/a$1.24+4.8%
Diluted shares, weighted2,445m2,439m2,424m+0.3%+0.9%
Shares outstanding at period end2,407m2,410m2,406m-0.1%+0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2026Q4 FY2025Q1 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity81,18681,54478,109-0.4%+3.9%
Debt54,98747,93352,252+14.7%+5.2%
Other liabilities64,72169,73363,310-7.2%+2.2%
Total liabilities and equity200,894199,210193,671+0.8%+3.7%
Fixed assets23,27023,16920,871+0.4%+11.5%
Goodwill48,55848,77244,468-0.4%+9.2%
Intangible assets49,06150,40336,755-2.7%+33.5%
Investments363393307-7.6%+18.2%
Cash and equivalents21,68819,70938,474+10.0%-43.6%
Receivables17,72117,17816,020+3.2%+10.6%
Inventory14,58314,19112,659+2.8%+15.2%
Other assets25,65025,39524,117+1.0%+6.4%
Total assets200,894199,210193,671+0.8%+3.7%

Questions

What was Johnson & Johnson's revenue in Q1 FY2026?

Johnson & Johnson (JNJ) reported revenue of $24.1 billion for Q1 FY2026, the quarter ended 29 March 2026, up 9.9% on the same quarter a year earlier.

How much did Johnson & Johnson earn in Q1 FY2026?

Net income for Q1 FY2026 was $5.2 billion, down 52.4% on the year, and diluted earnings per share $2.14.

When did Johnson & Johnson report Q1 FY2026 results?

Johnson & Johnson filed its 10-Q for the quarter ended 29 March 2026 with the SEC on 22 April 2026.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022 †Q2 FY2022 †Q3 FY2022 †Q4 FY2022Q1 FY2023 †Q2 FY2023 †Q3 FY2023Q4 FY2023 †Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue24,80419,84020,21519,99619,93920,89421,51921,35121,39521,38322,44722,47122,52021,89323,74323,99324,56424,06225,31025,399
Cost of revenue7,9557,5987,9196,1727,7656,6876,4626,6066,7986,5116,8696,9637,1287,3577,6287,3037,9688,1068,0518,097
Gross profit16,84913,82213,89313,82413,85514,20715,05714,74514,59714,87215,57815,50815,39214,53616,11516,69016,59615,95617,25917,302
Gross margin68%70%69%69%69%68%70%69%68%70%69%69%68%66%68%70%68%66%68%68%
R&D4,7203,4623,7033,4853,8413,4553,7033,4474,2463,5423,4404,9525,2983,2253,5163,6724,2523,5273,6534,652
SG&A7,1545,9386,2264,9756,5124,9065,3965,4005,8105,2575,6815,4786,4535,1125,8895,9226,7536,0346,4326,285
Interest expense60.010.038.051.017721234619219.0155270193137204308245214272281217
Pre-tax income4,8365,2035,1445,1723,840-1,2876,3065,2174,8263,7145,7483,3383,88713,6316,4917,4934,9665,9906,74734.0
Tax rate2%14%20%17%18%n/a15%17%14%12%18%19%12%19%15%31%-3%13%18%-518%
Net income4,7365,1494,8144,4583,520-68.05,14426,0284,0493,2554,6862,6943,43110,9995,5375,1525,1165,2355,534210
Net margin19%26%24%22%18%-0%24%122%19%15%21%12%15%50%23%21%21%22%22%1%
Diluted EPS$1.77$1.93$1.80$1.68$1.33-$0.03$1.96$10.21$1.67$1.34$1.93$1.11$1.41$4.54$2.29$2.12$2.10$2.14$2.27$0.09
Operating cash flow5,7323,9795,5816,2845,3503,2574,1827,4897,8633,6575,6337,9936,9834,1743,8789,1697,3092,5148,6167,720
Capital expenditure1,4156078639521,5878631,1249671,5898079761,0291,6127951,0431,1571,8371,0491,3211,362
Free cash flow4,3173,3724,7185,3323,7632,3943,0586,5226,2742,8504,6576,9645,3713,3792,8358,0125,4721,4657,2956,358
Buybacks9961,5779732,1651,3203,5373819202161,4751365392822,1270.01,9021,9244,0282211,709
Dividends paid2,7912,7872,9712,9702,9542,9423,0922,8712,8652,8692,9852,9852,9842,9893,1293,1323,1313,1313,2273,227
Shares outstanding2,629m2,631m2,629m2,614m2,409m2,599m2,599m2,407m2,409m2,407m2,407m2,408m2,408m2,406m2,408m2,409m2,410m2,407m2,410m2,407m
Filing10-K10-K10-K10-Q10-K10-K10-K10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 29 March 2026, filed 22 April 2026: the filing.